2021 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: a review of current data and applications on risk stratification and management

H Ali, A Bacigalupo - American Journal of Hematology, 2021 - Wiley Online Library
The number of patients with myelofibrosis (MF) undergoing an allogeneic hemopoietic stem
cell transplantation (HSCT) is increasing: in the analysis of the European Group for Blood …

Emerging drugs for the treatment of myelofibrosis: Phase II & III clinical trials

D Tremblay, R Hoffman - Expert Opinion on Emerging Drugs, 2021 - Taylor & Francis
Introduction Myelofibrosis is a clonal hematologic malignancy with clinical manifestations
that include cytopenias, debilitating constitutional symptoms, splenomegaly, bone marrow …

[PDF][PDF] Regímenes de acondicionamiento Intensidad del régimen de acondicionamiento (RA)

SELT DE DONANTE, SLAF DE CPH - Trasplante de células progenitoras … - sah.org.ar
Se utiliza el índice de Sorror basado en el índice de Charlson. Según las comorbilidades y
su gravedad se categoriza al paciente en bajo riesgo (índice 0), riesgo intermedio (índice 1 …